RxDoctor Payments Data

Nata Parnes, MD

Orthopaedic Surgery · Carthage, NYNPI 1366638728

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,993 of the $14,106 with a category attached, or 85.0%. Medical Device Business Services, Inc. accounts for 77.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $10,086 and has fallen 99.4% since, to $57 in 2025.

$14,106in general payments, 2019–2025

Across 49 payments — averaging $287.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$11K
  • Depuy Synthes Products, Inc.$2K
  • Johnson & Johnson$606
  • Smith+Nephew$329
  • Pacira Pharmaceuticals Incorporated$93
  • DJO, LLC$15
$112,389in ownership & investment interests, 2019–2025

Across 1 payment — averaging $112,389 each. An ownership or investment interest held by the physician or an immediate family member.

  • Zurimed Technologies Inc.$112K

What the payments were for

  • Consulting fees$11,99385%
  • Travel & lodging$8766%
  • Food & beverage$1,2379%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,106 in reported general payments places this provider in the 70th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$9,903
Medicare patients
27
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Carthage

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →